Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Lymphocytic Leukemia

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro

Leukemia volume 20, pages 1073–1079 (2006)Cite this article

Abstract

We have studied the in vitro actions of the sesquiterpene lactone parthenolide (PTL) on cells isolated from patients with chronic lymphocytic leukemia (CLL). Dye reduction viability assays showed that the median LD50 for PTL was 6.2 μ M (n=78). Fifteen of these isolates were relatively resistant to the conventional agent chlorambucil but retained sensitivity to PTL. Brief exposures to PTL (1–3 h) were sufficient to induce caspase activation and commitment to cell death. Chronic lymphocytic leukemia cells were more sensitive towards PTL than were normal T lymphocytes or CD34+ haematopoietic progenitor cells. The mechanism of cell killing was via PTL-induced generation of reactive oxygen species, resulting in turn in a proapoptotic Bax conformational change, release of mitochondrial cytochrome c and caspase activation. Parthenolide also decreased nuclear levels of the antiapoptotic transcription factor nuclear factor-kappa B and diminished phosphorylation of its negative regulator IκB. Killing of CLL cells by PTL was apparently independent of p53 induction. This is the first report showing the relative selectivity of PTL towards CLL cells. The data here warrant further investigation of this class of natural product as potential therapeutic agents for CLL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.

    Article  CAS  Google Scholar 

  2. Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE et al. Long-term follow up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimes as initial therapy. Blood 1998; 92: 1165–1171.

    CAS  PubMed  Google Scholar 

  3. Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750–1757.

    Article  CAS  Google Scholar 

  4. Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S et al. Infection in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998; 129: 559–566.

    Article  CAS  Google Scholar 

  5. Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC et al. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 2004; 104: 1428–1434.

    Article  CAS  Google Scholar 

  6. Pettitt AR, Sherrington PD, Stewart G, Cawley JC, Taylor AM, Stankovic T . p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001; 98: 814–822.

    Article  CAS  Google Scholar 

  7. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR . Relationship between p53 dysfunction, CD38 expression and IgVH mutation in chronic lymphocytic leukemia. Blood 2002; 100: 1404–1409.

    Article  CAS  Google Scholar 

  8. Shanafelt TD, Geyer SM, Kay NE . Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004; 103: 1202–1210.

    Article  CAS  Google Scholar 

  9. Pepper CJ, Hambly RM, Fegan CD, Delavault P, Thurston DE . The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill. Cancer Res 2004; 64: 6750–6755.

    Article  CAS  Google Scholar 

  10. Shanafelt TD, Lee YK, Bone ND, Strege AK, Jelinek DF, Kay NE et al. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Blood 2005; 105: 2099–2106.

    Article  CAS  Google Scholar 

  11. Campas C, Lopez JM, Santidrian AF, Barragan M, Bellosillo B, Colomer D et al. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 2003; 101: 3674–3680.

    Article  CAS  Google Scholar 

  12. Duechler M, Shehata M, Schwarzmeier JD, Hoelbl A, Hilgarth M, Hubmann R . Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia 2005; 19: 260–267.

    Article  CAS  Google Scholar 

  13. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE . VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 2004; 104: 788–794.

    Article  CAS  Google Scholar 

  14. Campas C, Dalmau M, Montaner B, Barragan M, Bellosillo B, Colomer D et al. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia 2003; 17: 746–750.

    Article  CAS  Google Scholar 

  15. Knight DW . Feverfew: chemistry and biological activity. Nat Prod Rep 1995; 12: 271–276.

    Article  CAS  Google Scholar 

  16. Wen J, You KR, Lee SY, Song CH, Kim DG . Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 2002; 277: 38954–38964.

    Article  CAS  Google Scholar 

  17. Park JH, Liu L, Kim IH, Kim JH, You KR, Kim DG . Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells. Cancer Res 2005; 65: 2804–2814.

    Article  CAS  Google Scholar 

  18. Kim JH, Liu L, Lee SO, Kim YT, You KR, Kim DG . Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis. Cancer Res 2005; 65: 6312–6320.

    Article  CAS  Google Scholar 

  19. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005; 105: 4163–4169.

    Article  CAS  Google Scholar 

  20. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM . The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IκB kinase. Chem Biol 2001; 8: 759–766.

    Article  CAS  Google Scholar 

  21. Jones DT, Addison E, North JM, Lowdell MW, Hoffbrand AV, Mehta AB et al. Geldanamycin and herbimycin A induce apoptotic killing of chronic lymphocytic leukemia cells and augment the cells' response to cytotoxic drugs. Blood 2004; 103: 1855–1861.

    Article  CAS  Google Scholar 

  22. Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, Dorken B et al. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity. Leukemia 2001; 15: 921–928.

    Article  CAS  Google Scholar 

  23. Posovszky C, Friesen C, Herr I, Debatin KM . Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T lymphocyte-mediated apoptosis. Leukemia 1999; 13: 400–409.

    Article  CAS  Google Scholar 

  24. Ramsby ML, Makowski GS . Differential detergent fractionation of eukaryotic cells. Analysis by two-dimensional gel electrophoresis. Methods Mol Biol 1999; 112: 53–66.

    CAS  PubMed  Google Scholar 

  25. Liu FT, Newland AC, Jia L . Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia. Biochem Biophys Res Commun 2003; 310: 956–962.

    Article  CAS  Google Scholar 

  26. Cory S, Adams JM . The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647–656.

    Article  CAS  Google Scholar 

  27. Bellosillo B, Villamor N, Lopez-Guillermo A, Marce S, Bosch F, Campo E et al. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Blood 2002; 100: 1810–1816.

    Article  CAS  Google Scholar 

  28. Stilgenbauer S, Bullinger L, Lichter P, Dohner H, German CLL Study Group (GCLLSG). Chronic lymphocytic leukemia. Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course. Leukemia 2002; 16: 993–1007.

    Article  CAS  Google Scholar 

  29. Komarov PG, Komarova EA, Kondratov RV, Kristov-Tselkov K, Coon JS, Chernov MV et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285: 1733–1737.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Leukemia Research Fund, UK.

Author information

Authors and Affiliations

  1. Department of Hematology, Royal Free and University College Medical School, London, UK

    A J Steele, D T Jones, K Ganeshaguru, V M Duke, B C Yogashangary, J M North, M W Lowdell, P D Kottaridis, A B Mehta, A G Prentice, A V Hoffbrand & R G Wickremasinghe

Authors
  1. A J Steele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D T Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Ganeshaguru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V M Duke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B C Yogashangary
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J M North
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M W Lowdell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P D Kottaridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A B Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A G Prentice
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A V Hoffbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R G Wickremasinghe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R G Wickremasinghe.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steele, A., Jones, D., Ganeshaguru, K. et al. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia 20, 1073–1079 (2006). https://doi.org/10.1038/sj.leu.2404230

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404230

Keywords

This article is cited by

Search

Advanced search

Quick links